What is CGON stock price today?

Visit our real-time dashboard for the current CGON stock price and live market data.

Is CGON stock going up or down today?

CGON stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CGON stock now?

The decision to buy CGON depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CGON a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CGON based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CGON stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CGON is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CGON's P/E ratio?

P/E ratio data for CGON will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CGON's market cap?

CGON (CG Oncology, Inc. Common stock) has a market capitalization of $4.74 billion, making it a small-cap stock.

What is CGON's price to book ratio?

Price-to-book ratio for CGON is available on our dashboard along with other valuation metrics.

Does CGON pay dividends?

CGON does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is CGON's dividend yield?

CGON does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is CGON stock a good long-term investment?

CGON's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CGON's revenue growth rate?

Revenue growth data for CGON is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CGON are available on our dashboard with complete income statement analysis.

What are the risks of investing in CGON?

Key risks for CGON include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CGON compare to its competitors?

Compare CGON to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CGON's performance and positioning.

What is CGON's stock price target for 2026?

Visit our prediction page for AI-powered price targets for CGON with bull, base, and bear case scenarios.

What do analysts say about CGON?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CGON. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CGON's next earnings report?

CGON reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CGON - CG Oncology, Inc. Common stock

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About CG Oncology, Inc. Common stock

CG Oncology, Inc. Common stock (CGON) common stock

Price Chart

Loading chart...

CGON Key Statistics

Market Cap

$4.74B

How CGON Compares to Peers

CGON is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
CGON(This stock)	$4.74B	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 18, 2026 at 7:44 AM EDT

Ready to invest in CGON?

Commission-free trading available. Affiliate links.

CGON Lician Score

5% confidence

4.0/10

Neutral

CGON has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates CGONacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

CGON Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for CGON

Dashboard

Enter a ticker to analyze